vegf

Documents about vegf

• The Effect of Glioblastoma PSMA Expression Following Tumour VEGF Blockade From Bevacizumab#880188ClinicalTrials.gov
• VEGF Signaling Promotes Cell Growth and Metastasis in Intrahepatic Cholangiocarcinoma in a VEGF Receptor Mediated Pathway#886538ClinicalTrials.gov
• VEGF Signaling Promotes Cell Growth and Metastasis in Extrahepatic Cholangiocarcinoma in a VEGF Receptor Mediated Pathway (ECC)#899977ClinicalTrials.gov
• Protective VEGF Inhibition for Isotoxic Dose Escalation in Glioblastoma#912598ClinicalTrials.gov
• Intravitreal Aflibercept Injection for Radiation Retinopathy#979108ClinicalTrials.gov
• CD31+ T-cells express greater VEGF-A and CXCR4 levels than CD31- counterparts with VEGF-A expression exacerbated with advancing age#146494bioRxiv / medRxiv
• Endocan, VEGF and TNF-alpha Levels in Periodontal Disease and After Treatment#861767ClinicalTrials.gov
• Effect of Expression of CD74 and VEGF on Outcome of Treatment in Patients With Malignant Pleural Mesothelioma#837740ClinicalTrials.gov
• Valva aórtica suína descelularizada e funcionalizada com VEGF: estratégias para aumento da biocompatibilidade e hemocompatibilidade.#358781Repositório da UFES
• Valproic Acid and Bevacizumab in Patients With Advanced Cancer#981916ClinicalTrials.gov
• Bevacizumab and Paclitaxel for Neuroendocrine Tumors of the Cervix#872835ClinicalTrials.gov
• Anti-vascular Endothelial Growth Factor (Anti-VEGF) Monotherapy vs Anti-VEGF Followed by Subthreshold Micropulse Laser for Treating Severe Diabetic Macular Oedema When the Central Retina Goes <400 Microns#896765ClinicalTrials.gov
• A retrospective, cross-sectional analysis of the dental status and needs of patients taking vascular endothelial growth factor (VEGF) antagonists#989846ScholarlyCommons
• Efficacy and Safety of VEGF Trap Eye in Diabetic Macular Edema (DME) With Central Involvement#843565ClinicalTrials.gov
• Vascular Endothelial Growth Factor (VEGF) Imaging Before and During Everolimus Treatment for Renal Cell Carcinoma#896938ClinicalTrials.gov
• High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors#846802ClinicalTrials.gov
• Folfox-B Study for Patients With Colorectal Liver Metastases#848755ClinicalTrials.gov
• Safety and Efficacy of the Fully Humanized Anti - VEGF Monoclonal Antibody LYN00101#877145ClinicalTrials.gov
• A Study Of Crizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors.#915907ClinicalTrials.gov
• Ivonescimab Combined With Chemotherapy for the Treatment of Leptomeningeal Metastases Failed to EGFR-TKIs#888241ClinicalTrials.gov
• Effect of a Hyperproteic Hyperenergetic Enteral Formula on Body Composition and VEGF in AML During Hospital Stay#826153ClinicalTrials.gov
• Vascular Patterning affects Intramembranous Ossification through HIF1α-Vegf Signaling#300118bioRxiv / medRxiv
• New perspectives on VEGF signalling in Alzheimer's disease.#422805NCBI PubMed Central
• Macular Function During Anti-VEGF Treatment#885028ClinicalTrials.gov
• CD31 ⁺ T-cells express greater VEGF-A and CXCR4 levels than CD31 ^- counterparts with VEGF-A expression exacerbated with advancing age#149892Unpaywall
• A Study to Evaluate the Efficacy and Safety of KSI-301, an Anti-VEGF Antibody Biopolymer Conjugate, Versus Aflibercept in Patients With Neovascular (Wet) Age-Related Macular Degeneration.#902605ClinicalTrials.gov
• Early increase of plasma soluble VEGFR-2 is associated with clinical benefit from second-line treatment of paclitaxel and ramucirumab in advanced gastric cancer#185551IRIS
• Five-Year Prescription Trends in Anti-VEGF Utilization: A Randomized Sampling of Real-World Injection Patterns#215008DigitalCommons@WayneState
• VEGF Concentrations After Intravitreal Bevacizumab vs Ranibizumab as a Treatment for Type 1 ROP#967510ClinicalTrials.gov
• Neovascular age-related macular degeneration management - Beyond anti-VEGF.#251170NCBI PubMed Central
• Intraperitoneal Paclitaxel and Carboplatin With IV Avastin Therapy in Patients With Carcinomas of Mullerian Origin#884790ClinicalTrials.gov
• A genetic determinant of VEGF-A levels is associated with telomere attrition#288334HAL (France)
• A signal sequence multi-leucine motif regulates VEGF receptor signaling.#785596NCBI PubMed Central
• Correlation of VEGF-A and Fluid Balance in Septic Shock#861851ClinicalTrials.gov
• CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors#847862ClinicalTrials.gov
• Open Label, Single Arm Trial to Characterize Patients With Metastatic RCC Treated With Everolimus After Failure of the First VEGF-targeted Therapy (MARC-2)#866404ClinicalTrials.gov
• Phase II Combination Steroid and Anti-VEGF for Persistent DME#300381ClinicalTrials.gov
• Lung Ultrasound in PD Patients#849252ClinicalTrials.gov
• POEMS Syndrome Treatment With Lenalidomide#908004ClinicalTrials.gov
• Genetics in Non-response to Anti-VEGF Treatment in Exudative AMD#967308ClinicalTrials.gov
• Aptamer-Based Delivery Systems for VEGF and NGF Modulation in Ocular Therapies.#297352NCBI PubMed Central
• Генетические маркеры эффективности анти-VEGF терапии при возрастной макулярной дегенерации#619342CyberLeninka
• A Trial of AK112 (PD1/VEGF Bispecific) in Combination With Chemotherapy in Patients With NSCLC#831942ClinicalTrials.gov
• Understand the Association Between Peritoneal Dialysis Status and Gene Polymorphisms of VEGF and KDR#980026ClinicalTrials.gov
• Is VEGF a key target of cotinine and other potential therapies against Alzheimer disease?#260607Repositorio USS
• A Study of AK112, a PD-1/VEGF Bispecific Antibody, for Advanced Solid Tumors#349947ClinicalTrials.gov
• Novel needle for intravitreal injections does not affect biological activity of anti-VEGF drugs#449068JLUpub
• Use of Spectral OCT in Combination Therapy#831057ClinicalTrials.gov
• PTC299 for Treatment of Neurofibromatosis Type 2#874244ClinicalTrials.gov
• Ischémie et angiogénèse tumorale : effets des carences en glucose et en acides aminés sur l'expression du VEGF-A par les cellules tumorales et implication de la réponse (« Unfolded Protein Response »).#374548HAL (France)